Sustained Delivery of a SARS-CoV-2 Subunit Vaccine in An Adjuvanted Hydrogel Depot Enhances Vaccine Responses in Nonhuman Primates
Ou, B. S.; Hu, M.; Yan, J.; Santagata, J. M.; Saouaf, O. M.; Eppler, H. B.; Lujan, V.; Song, Y. E.; Grifoni, A.; Klich, J.; Sette, A.; Utz, A.; Suthar, M. S.; Eckman, N.; Feng, Y.; Baillet, J.; Rogers, K. A.; Shirreff, L. M.; Aoyagi, G. J.; Valdez, A. S.; Ravichandran, R.; King, N. P.; Fontenot, J.; Villinger, F.; Pulendran, B.; Appel, E.
Show abstract
While natural infections expose the immune system for days to weeks of inflammation and antigen presentation, immunizations with conventional bolus vaccines often lead to rapid clearance of antigens and adjuvants. Prolonged exposure to vaccines using controlled delivery devices or repeated dosing regimens has been shown to enhance germinal center reactions, leading to improved humoral responses, including increased magnitude of antibody titers and enhanced neutralizing activity. Herein, we report the use of injectable polymer-nanoparticle (PNP) hydrogels as a vaccine depot technology for sustained delivery of the clinically relevant SARS-CoV-2 Hexapro subunit antigen and a toll-like receptor agonist adjuvant. In mice, we demonstrated that PNP hydrogel vaccines enhanced germinal center responses and antibody responses relative to bolus vaccination. In nonhuman primates, hydrogel vaccines induced enhanced and durable antibody responses against wildtype and variants of concern such as Omicron BA.5 compared to bolus vaccination. We report the first use of a biomaterials-based approach for sustained delivery of vaccines in nonhuman primates, further advancing toward clinical translation.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing 96%
- SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity Through B Cell Antigen Presentation 96%
- Immunofilaments Provide a Nanoscale Platform for In Vivo T Cell Expansion and Cancer Immunotherapy 96%
Similar papers in this journal
- Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2 98%
- Nanoscale biodegradable printing for designed tuneability of vaccine delivery kinetics 94%
- Extracellular matrix scaffold-assisted tumor vaccines induce tumor regression and long-term immune memory 94%
Similar papers in this journal
- A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses 96%
- Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine 96%
- Dextran-based T-cell expansion nanoparticles for manufacturing CAR T cells with augmented efficacy 95%
Similar papers in this journal
- Sustained vaccine exposure elicits more rapid, consistent, and broad humoral immune responses to multivalent influenza vaccines 97%
- Injectable Nanoparticle-Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies 95%
- Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and Specificity 94%
Similar papers in this journal
- Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant 97%
- Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge 95%
- HIV Virion Capturing Liposomes for Therapeutic Vaccination 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.